DNB Fund - Biotechnology A EUR (Acc)
UMushroom community rating:
0.00
0 votes
No rating yet
NegativeNeutralPositive
DNB Fund – Biotechnology focuses on investing in the stocks of large to medium-sized companies within the biotechnology, diagnostics, pharmaceuticals, biomedicine, gene therapy, and other healthcare-related sectors. Managed with a fundamental investment approach, the fund seeks long-term positive returns by selecting firms that adhere to strong governance practices. It maintains geographic flexibility, allowing it to choose the best opportunities from global markets to build a diverse and specialized portfolio in the healthcare and biotech industries.
Content summarized by AI chatbot
Tags:
healthcarebiotechnologynasdaq biotechnology index
Ratings & reviews
0.00
0 votes
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
OTHER SHARE CLASSES OF THIS FUND
DNB Fund - Biotechnology N CHF (Acc)
DNB Fund - Biotechnology N CHF (Acc)
DNB Fund - Biotechnology N CHF (Acc)
Valor: 13492065
Annual Return
-50%0%+50%
Risk level
110
1.41%CHF 116.55
DNB Fund - Biotechnology N EUR (Acc)
DNB Fund - Biotechnology N EUR (Acc)
DNB Fund - Biotechnology N EUR (Acc)
Valor: 13491841
Annual Return
-50%0%+50%
Risk level
110
1.25%EUR 122.45
DNB Fund - Biotechnology C1 EUR (Acc)
DNB Fund - Biotechnology C1 EUR (Acc)
DNB Fund - Biotechnology C1 EUR (Acc)
Valor: 13491849
Annual Return
-50%0%+50%
Risk level
110
1.25%EUR 122.75
DNB Fund - Biotechnology C1 CHF (Acc)
DNB Fund - Biotechnology C1 CHF (Acc)
DNB Fund - Biotechnology C1 CHF (Acc)
Valor: 13492064